Diethanolamine added to CIR permanent agenda due to carcinogenic concerns.
This article was originally published in The Rose Sheet
Executive Summary
NTP DIETHANOLAMINE STUDY RESULTS "REQUIRE PROMPT ATTENTION," FDA Office of Cosmetics & Colors Director John Bailey, PhD, advised the Cosmetic Ingredient Review Expert Panel at a meeting in Washington, D.C. March 20. Following the agency's preliminary review of the National Toxicology Program's study on diethanolamine (DEA), Bailey concluded the findings were "very relevant" because of the "public health implications" and "significant enough" to "require prompt attention."